| Reference number: | 01KA1630 |
| Funding amount: | 2.000.000 EUR |
| Funding Period: | 2016 - 2018 |
| Project leader: | Dr. Michael Makanga |
| Address: |
European & Developing Countries Clinical Trials Partnership (EDCTP) Anna van Saksenlaan 51 2593 HW The Hague (NL) |
PanACEA, a consortium funded previously by EDCTP has managed an extensive drug development portfolio, delivering 6 clinical trials. The present project proposes to continue and expand the programme to accelerate the development of new anti-tuberculosis drug regimens. It will take full advantage of innovative trial designs, new microbiological markers of treatment response, pharmacokinetic-pharmacodynamic analyses and novel modelling techniques developed previously.
